eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Draft Guidance for Clinical Investigators, Industry, and FDA Staff; Availability Financial Disclosure by Clinical Investigators (FDA-1999-D-0792)

Draft Guidance for Clinical Investigators, Industry, and FDA Staff; Availability Financial Disclosure by Clinical Investigators (FDA-1999-D-0792)

Document ID: FDA-1999-D-0742-0001
Document Type: Notice
Agency: Food And Drug Administration
Topics: No Topics associated with this document
Federal Register Number: 2011-12623
View Document:  View as format pdf View as format html

Details Information

Document Subtype: NAD-Notice of Availability of Data
Received Date: May 24 2011, at 12:00 AM Eastern Daylight Time
Start-End Page: 30175 - 30176
Page Count: 2
Comment Start Date: May 24 2011, at 12:00 AM Eastern Standard Time
Comment Due Date: July 25 2011, at 11:59 PM Eastern Standard Time

Comments

    View All
Total: 9
Council on Governmental Relations (COGR) - Comment
Posted: 09/21/2011     ID: FDA-1999-D-0742-0006

Jul 25,2011 11:59 PM ET
Pharmaceutical Research and Manufacturers of America (PhRMA) - Comment
Posted: 09/21/2011     ID: FDA-1999-D-0742-0007

Jul 25,2011 11:59 PM ET
Biotechnology Industry Organization (Bio) - Comment
Posted: 09/21/2011     ID: FDA-1999-D-0742-0010

Jul 25,2011 11:59 PM ET
Washington Legal Foundation - Comment
Posted: 09/21/2011     ID: FDA-1999-D-0742-0011

Jul 25,2011 11:59 PM ET
Sanofi aventis - Comment
Posted: 09/21/2011     ID: FDA-1999-D-0742-0012

Jul 25,2011 11:59 PM ET

Related Documents

Total: 0
No documents available.